Royal Melbourne Hospital (RMH)

Hospital


Location: Melbourne, Australia (AU) AU

ISNI: 0000000406241200

ROR: https://ror.org/005bvs909

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey (2023) Naveen R, Thakare D, Kuwana M, Pauling J, Day J, Joshi M, Parodis I, et al. Journal article Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys (2023) Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, et al. Journal article Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study (2023) Sandhu NK, Ravichandraan N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, et al. Journal article Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study. (2023) Naveen R, Nikiphorou E, Joshi M, Sen P, Lindblom J, Agarwal V, Lilleker JB, et al. Journal article Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023) Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023) Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, et al. Journal article Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study (2023) Shinjo SK, Kim M, Hoff LS, Missé RG, Sen P, Naveen R, Day J, et al. Journal article Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, et al. Journal article, Letter COVAD survey 2 long-term outcomes: unmet need and protocol (2022) Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, et al. Journal article Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey (2022) Yoshida A, Kim M, Kuwana M, Ravichandran N, Makol A, Sen P, Lilleker JB, et al. Journal article
1 2 3 4